ali zarezadeh mehrabadi

Cited by

	All	Since 2019
Citations	154	154
h-index	5	5
i10-index	4	4

20212022202320243 35 71 45

Co-authors

nazanin aghamohamadiMs.c ImmunologyVerified email at iums.ac.ir
Reza FalakDepartment of Immunology, School of Medicine, Iran University of Medical SciencesVerified email at iums.ac.ir
MohammadAli HamidinejadPasteur Institute of Iran, Tehran, IranVerified email at pasteur.ac.ir
Hossein KhorramdelazadRafsanjan University of Medical Sciences, Rafsanjan, IranVerified email at rums.ac.ir
faezeh shahbairan university of medical sciencesVerified email at iums.ac.ir
Majid KhoshmirsafaDepartment of immunology, Iran University of Medical Sciences, Tehran, IranVerified email at tak.iums.ac.ir
Mohammad Hossein KazemiPhD in Medical Immunology, Postdoctoral Researcher at University of Southern California, Los AngelesVerified email at usc.edu
Reza JafariUrmia University of Medical SciencesVerified email at umsu.ac.ir
Reza YazdaniThomas Jefferson UniversityVerified email at jefferson.edu
Hassan AbolhassaniKarolinska InstitutetVerified email at ki.se
Nima RezaeiTehran University of Medical Sciences; Universal Scientific Education and Research Network (USERN)Verified email at tums.ac.ir
Asghar aghamohammadiResearch Center for Immuynodeficiency, Tehran University of medical Sciences

ali zarezadeh mehrabadi

Ms.c IMMUNOLOGY

Verified email at iums.ac.ir

Immunodeficiency cancer immunology immunotherapy


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
Therapeutic potential of CAR T cell in malignancies: A scoping review A Zarezadeh mehrabadi, R Ranjbar, M Farzanehpour, A Shahriary, ... Biomedicine & Pharmacotherapy 146, 112512, 2022	90	2022
The roles of interleukin‐1 receptor accessory protein in certain inflammatory conditions A Zarezadeh Mehrabadi, N Aghamohamadi, M Khoshmirsafa, ... Immunology, 2022	20	2022
Overview of the pre-clinical and clinical studies about the use of CAR-T cell therapy of cancer combined with oncolytic viruses A Zarezadeh Mehrabadi, F Roozbahani, R Ranjbar, M Farzanehpour, ... World Journal of Surgical Oncology 20, 1-10, 2022	14	2022
Type-I interferons in the immunopathogenesis and treatment of Coronavirus disease 2019 H Khorramdelazad, MH Kazemi, M Azimi, A Aghamajidi, AZ Mehrabadi, ... European journal of pharmacology 927, 175051, 2022	12	2022
Age-dependent immune responses in COVID-19-mediated liver injury: focus on cytokines N Aghamohamadi, F Shahba, A Zarezadeh Mehrabadi, ... Frontiers in Endocrinology 14, 1139692, 2023	6	2023
Comprehensive assessment of skin disorders in patients with common variable immunodeficiency (CVID) A Zarezadeh Mehrabadi, N Aghamohamadi, H Abolhassani, ... Journal of Clinical Immunology 42 (3), 653-664, 2022	5	2022
Pentoxifylline changes the balance of immune cell population in breast tumor-infiltrating lymphocytes MH Kazemi, M Shokrollahi Barough, Z Momeni-Varposhti, ... Medical Oncology 40 (6), 168, 2023	3	2023
Interleukin-1 receptor accessory protein (IL-1RAP): A magic bullet candidate for immunotherapy of human malignancies AZ Mehrabadi, F Shahba, H Khorramdelazad, N Aghamohammadi, ... Critical Reviews in Oncology/Hematology 193, 104200, 2024	2	2024
Activated PI3K-Delta Syndrome: Pathogenesis, Clinical Manifestations, Diagnosis, Classification, and Management N Aghamohamadi, A Zarezadeh mehrabadi Immunology and Genetics Journal 3 (3), 2020	2	2020
Revolutionizing cancer treatment: the power of bi-and tri-specific T-cell engagers in oncolytic virotherapy A Zarezadeh Mehrabadi, M Tat, A Ghorbani Alvanegh, F Roozbahani, ... Frontiers in Immunology 15, 1343378, 2024		2024

The system can't perform the operation now. Try again later.

Articles 1–10

Citations per year

Duplicate citations

Merged citations

Add co-authorsCo-authors

Follow

Cited by

Co-authors